BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16303698)

  • 1. Graves' disease in children and adolescents: response to long-term treatment.
    Barrio R; López-Capapé M; Martinez-Badás I; Carrillo A; Moreno JC; Alonso M
    Acta Paediatr; 2005 Nov; 94(11):1583-9. PubMed ID: 16303698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile thyrotoxicosis--a South Island, New Zealand experience with long-term outcome.
    Brownlie BE; Hunt PJ; Turner JG
    N Z Med J; 2010 Apr; 123(1313):23-31. PubMed ID: 20581892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotoxicosis in children: treatment and outcome.
    Jaruratanasirikul S; Leethanaporn K; Sriplung H
    J Med Assoc Thai; 2006 Jul; 89(7):967-73. PubMed ID: 16881428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reflections on the therapeutic goal in Basedow hyperthyroidism].
    Höfer R
    Acta Med Austriaca; 1987; 14(3-4):70-2. PubMed ID: 2447737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up comparison of short-term versus 1-year antithyroid drug therapy for the thyrotoxicosis of Graves' disease.
    Bouma DJ; Kammer H; Greer MA
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1138-42. PubMed ID: 6182155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
    Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
    Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM; Shawkat W
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of antithyroid medication and radioiodine therapy in pediatric Graves' disease.
    Leu SW; Chi CS; Shu SG
    Acta Paediatr Taiwan; 2003; 44(4):220-6. PubMed ID: 14674226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective study on the relationship between treatment duration of antithyroid drug and remission rate of Graves' disease].
    Liu C; Duan Y; Wu X
    Zhonghua Yi Xue Za Zhi; 2000 Nov; 80(11):835-7. PubMed ID: 11218878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Childhood Graves' disease].
    Sasaki N; Sato K
    Nihon Rinsho; 2006 Dec; 64(12):2308-11. PubMed ID: 17154097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an artificial neural network to predict Graves' disease outcome within 2 years of drug withdrawal.
    Orunesu E; Bagnasco M; Salmaso C; Altrinetti V; Bernasconi D; Del Monte P; Pesce G; Marugo M; Mela GS
    Eur J Clin Invest; 2004 Mar; 34(3):210-7. PubMed ID: 15025680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of thyroidectomy for Graves' disease: A meta-analysis.
    Palit TK; Miller CC; Miltenburg DM
    J Surg Res; 2000 May; 90(2):161-5. PubMed ID: 10792958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study.
    Glaser NS; Styne DM;
    Pediatrics; 2008 Mar; 121(3):e481-8. PubMed ID: 18267979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.